Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3952 Target Snapshot

Kappa-type opioid receptor · SINGLE PROTEIN · Cavia porcellus

3,034Compounds
731Assays
24Approved Drugs
3,529.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P41144. Use UniProt P41144 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P41144 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Kappa-type opioid receptor as ChEMBL target CHEMBL3952, mapped to UniProt P41144. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Kappa-type opioid receptor
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-13
ChEMBL target ID
CHEMBL3952
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P41144
Kappa-type opioid receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Kappa-type opioid receptor is the right protein anchor across sources, using UniProt P41144 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelKappa-type opioid receptor
UniProt AccessionP41144
Component TypeProtein
Sequence Length380 aa

Kappa-type opioid receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Kappa-type opioid receptor, mapped to UniProt P41144. Sequence length is 380 aa.

Mapped IDP41144
Review nameKappa-type opioid receptor
OrganismCavia porcellus
Clinical Profile

Clinical Phase Distribution

24
Approved
13
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC50661.0
KI2,812.0
EC5031.0
KD25.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4077003 11.0 Ki 0.01 Preclinical
CHEMBL425806 10.7 Ki 0.02 Preclinical
CHEMBL442323 10.7 Ki 0.02 Preclinical
CHEMBL415247 10.7 Ki 0.02 Preclinical
CHEMBL51204 10.7 Ki 0.02 Preclinical
CHEMBL266717 10.7 Ki 0.02 Preclinical
CHEMBL266515 10.68 Ki 0.021 Preclinical
CHEMBL4751305 10.66 Ki 0.022 Preclinical
CHEMBL415330 10.64 Ki 0.023 Preclinical
CHEMBL438741 10.62 Ki 0.024 Preclinical
Distribution

pChEMBL Value Distribution

137
5.0
189
5.5
338
6.0
337
6.5
584
7.0
328
7.5
316
8.0
252
8.5
261
9.0
154
9.5
pChEMBL
Approved Drugs

Approved Drugs

ELUXADOLINE
CHEMBL2159122
Approved 2015
NALFURAFINE
CHEMBL267495
Approved 2009
NALFURAFINE HYDROCHLORIDE
CHEMBL490665
Approved 2009
ALVIMOPAN
CHEMBL270190
Approved 2008
METHYLNALTREXONE
CHEMBL1186579
Approved 2008
METHYLNALTREXONE BROMIDE
CHEMBL1201770
Approved 2008
NALMEFENE
CHEMBL982
Approved 1995
LEVORPHANOL
CHEMBL592
Approved 1991
NALTREXONE
CHEMBL19019
Approved 1984
MORPHINE
CHEMBL70
Approved 1984
BUPRENORPHINE
CHEMBL511142
Approved 1981
NALOXONE
CHEMBL80
Approved 1971
FENTANYL
CHEMBL596
Approved 1968
OXYMORPHONE
CHEMBL963
Approved 1959
OXYCODONE
CHEMBL656
Approved 1950
Assay Landscape

Assay Landscape

731
Total Assays
2,392
Tested Compounds
2
Assay Types
Binding — 598 assays, 2,392 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 263 623 7.4
cell membrane format 163 719 7.6
assay format 88 470 7.4
tissue-based format 68 290 7.8
cell-based format 8 264 7.4
organism-based format 7 13 7.5
cell-free format 1 13 7.6
Functional — 133 assays, 81 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 60 39 7.4
tissue-based format 52 19 7.9
cell membrane format 20 23 7.1
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine